Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need

Author:

Hirsch G1,Trusheim M1,Cobbs E2,Bala M3,Garner S4,Hartman D5,Isaacs K1,Lumpkin M5,Lim R6,Oye K1,Pezalla E7,Saltonstall P8,Selker H9

Affiliation:

1. Massachusetts Institute of TechnologyCambridge Massachusetts USA

2. MerckKenilworth New Jersey USA

3. SanofiSeattle Washington USA

4. National Institute for Health and Clinical Excellence (NICE)London UK

5. Bill and Melinda Gates FoundationSeattle Washington USA

6. Health CanadaOttawa Ontario Canada

7. AetnaHartford Connecticut USA

8. National Organization for Rare Disorders (NORD)Danbury Connecticut USA

9. Tufts UniversityBoston Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Alliance for Regenerative Medicine Releases 2015 Annual Data Report Highlighting Sector Trends and Metrics. (2016).

2. Hepatitis C drug costs leave many without care;Freyer F.;Boston Globe,2016

3. The risks of risk aversion in drug regulation

4. The FDA as a Public Health Agency

5. The special case of gene therapy pricing

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3